14-14-1　ⓔ文献

  1. Qian F, Watnick TJ, et al: The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease typeⅠ. Cell, 1996; 87: 979–987.

  2. 厚生労働省進行性腎障害調査研究班：多発性囊胞腎診療指針．日本腎臓学会誌，2011; 53: 556–583.

  3. Torres VE, Harris PC : Strategies targeting cAMP signaling in the treatment of polycystic kidney disease. J Am Soc Nephrol, 2014; 25: 18–32.

  4. Grantham JJ: Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med, 2008; 359: 1477–1485.

  5. Hogan MC, Norby SM: Evaluation and management of pain in autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis, 2010; 17: e1–e16.

  6. Contreras G, Mercado A, et al: Nephrotic syndrome in autosomal dominant polycystic kidney disease. J Am Soc Nephrol, 1995; 6: 1354–1359.

  7. Cadnapaphornchai MA, McFann K, et al: Prospective change in renal volume and function in children with ADPKD. Clin J Am Soc Nephrol, 2009; 4: 820–829.

  8. Chapman AB, Johnson A, et al: The renin–angiotensin–aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med, 1990; 323: 1091–1096.

  9. Nishiura JL, Neves RF, et al: Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol, 2009; 4: 838–844.

  10. Chauveau D, Prison Y, et al: Intracranial aneurysms in autosomal dominant polycystic kidney disease. Kidney Int, 1994; 45: 1140–1146.

  11. Vlak MH, Algra A, et al: Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta–analysis. Lancet Neurol, 2011; 10: 626–636.

  12. Torres VE, Harris PC: Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int, 2009; 76: 149–168.

  13. Higashihara E, Nutahara K, et al: Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan. Nephron, 1998; 80: 421–427.

  14. Torres VE, Chapman AB, et al : Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med, 2012; 367: 2407–2418.

  15. Schrier RW, Abebe KZ, et al: Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med, 2014; 371: 2255–2266.

  16. Torres VE, Abebe KZ, et al: Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease. Kidney Int, 2017; 91: 493–500.

  17. Harris PC, Torres VE: Polycystic kidney disease. Annu Rev Med, 2009; 60: 321–337.

  18. 石川　勲：ACDKの実態．日本透析医学会雑誌，2008; 23: 179–187.

  19. Hildebrandt F, Otto E: Molecular genetics of nephronophthisis and medullary cystic kidney disease. J Am Soc Nephrol, 2000; 11: 1753–1761.

  20. Eckardt KU, Alper SL, et al: Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management A KDIGO consensus report. Kidney Int, 2015; 88: 676–683.